Anti-Vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Report

Anti-Vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Beovu), By Disease (Diabetic Retinopathy, AMD), By Region (APAC, North America), And Segment Forecasts, 2021 - 2028

Report ID: GVR-4-68038-346-1
Number of Pages: 105
Format: Electronic (PDF)

Historical Range: 2017 - 2019
Industry: Healthcare

Market Segmentation

Anti-VEGF Therapeutics Product Outlook (Revenue, USD Million, 2017 - 2028)
- Eylea
- Lucentis
- Beovu
Anti-VEGF Therapeutics Disease Outlook (Revenue, USD Million, 2017 - 2028)
- Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
- Age-related Macular Degeneration
Anti-VEGF Therapeutics Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
  - North America Anti-VEGF Therapeutics Market, By Product
    - Eylea
    - Lucentis
    - Beovu
  - North America Anti-VEGF Therapeutics Market, By Disease
    - Macular Edema
    - Diabetic Retinopathy
    - Retinal Vein Occlusion
    - Age-related Macular Degeneration
  - U.S.
  - Canada
    - Canada Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Canada Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
- Europe
  - Europe Anti-VEGF Therapeutics Market, By Product
    - Eylea
    - Lucentis
    - Beovu
  - Europe Anti-VEGF Therapeutics Market, By Disease
    - Macular Edema
    - Diabetic Retinopathy
    - Retinal Vein Occlusion
    - Age-related Macular Degeneration
  - U.K.
    - U.K. Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - U.K. Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - Germany
    - Germany Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Germany Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - France
    - France Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - France Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - Italy
    - Italy Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Italy Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - Spain
    - Spain Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Spain Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
- Asia Pacific
- Latin America
  - Latin America Anti-VEGF Therapeutics Market, By Product
    - Eylea
    - Lucentis
    - Beovu
  - Latin America Anti-VEGF Therapeutics Market, By Disease
    - Macular Edema
    - Diabetic Retinopathy
    - Retinal Vein Occlusion
    - Age-related Macular Degeneration
  - Argentina
    - Argentina Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Argentina Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - Brazil
    - Brazil Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Brazil Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
  - Mexico
    - Mexico Anti-VEGF Therapeutics Market, By Product
      - Eylea
      - Lucentis
      - Beovu
    - Mexico Anti-VEGF Therapeutics Market, By Disease
      - Macular Edema
      - Diabetic Retinopathy
      - Retinal Vein Occlusion
      - Age-related Macular Degeneration
- Middle East & Africa

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2028
Market estimates and forecast for product segments up to 2028
Regional market size and forecast for product segments up to 2028
Market estimates and forecast for application segments up to 2028
Regional market size and forecast for application segments up to 2028
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.